Chr | Position | SNPID | Disease/Trait name | pvalue | PMID |
---|---|---|---|---|---|
19 | 17394124 | rs2363956 | Breast cancer risk (in BRCA1 mutation carriers) | 2.40E-10 | 20852631 |
19 | 17394124 | rs2363956 | Breast cancer risk (Excluding BRCA1 mutation carriers who developed ovarian cancer) | 6.50E-10 | 20852631 |
19 | 17394124 | rs2363956 | Breast cancer | 5.54E-09 | 20852631 |
19 | 17394124 | rs2363956 | "Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)" | 2.00E-08 | 24325915 |
19 | 17394124 | rs2363956 | "Breast cancer risk (Estrogen receptor, progesterone receptor and HER2 negative)" | 1.10E-07 | 20852631 |
19 | 17394124 | rs2363956 | Breast cancer risk (Excluding breast cancer cases diagnosed with breast cancer more than 5 years prior to study recruitment) | 8.50E-07 | 20852631 |
19 | 17394124 | rs2363956 | Breast cancer (Estrogen receptor negative breast cancer) | 1.69E-06 | 22976474 |
19 | 17394124 | rs2363956 | Breast cancer risk (BRCA1 Class 1 mutations only) | 6.50E-06 | 20852631 |
19 | 17394124 | rs2363956 | Breast cancer risk (BRCA1 Class 2 mutations only) | 1.30E-05 | 20852631 |
19 | 17394124 | rs2363956 | Breast cancer (Estrogen receptor negative breast cancer) | 3.00E-04 | 20852631 |
19 | 17394124 | rs2363956 | Breast cancer risk (Estrogen receptor or progesterone receptor negative) | 4.00E-04 | 20852631 |
19 | 17394124 | rs2363956 | Breast cancer | 8.08E-04 | 23468962 | Chr | Position | SNPID | Disease/Trait name | pvalue | PMID |
CopyRight © University of Miami, USA; Harbin Medical University, China